Breaking News

Molecular Profiles Expands Manufacturing Capabilities

Expansion allows for comprehensive Phase I-II requirements

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Molecular Profiles has begun construction of a new manufacturing facility at its site in Nottingham, investing $13.8 million to expand its current manufacturing capabilities. The expansion covers all services including formulation development, polymorph and salt selection, analytical services, materials characterization and clinical trial manufacturing. The new GMP facility, planned to open in late 2012, will provide an additional 30,000 sq. ft. of space, including six new GMP suites, new labs ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters